Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer Sam Ladjevardi, Gabriel Sandblom,

Slides:

Advertisements

Similar presentations

Volume 59, Issue 2, Pages (February 2011)

Advertisements

Volume 68, Issue 2, Pages (August 2015)

Volume 68, Issue 6, Pages (December 2015)

Volume 70, Issue 5, Pages (November 2016)

Volume 51, Issue 2, Pages (February 2007)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 58, Issue 4, Pages (October 2010)

Testosterone Therapy in Men With Prostate Cancer

Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer Marisa Warmuth,

Volume 53, Issue 4, Pages (April 2008)

Volume 60, Issue 2, Pages (August 2011)

Volume 61, Issue 5, Pages (May 2012)

Volume 73, Issue 6, Pages (June 2018)

Control of Prostate Cancer by Transrectal HIFU in 227 Patients

Volume 51, Issue 4, Pages (April 2007)

Histologic Grading of Noninvasive Papillary Urothelial Neoplasms

Volume 70, Issue 4, Pages (October 2016)

Volume 71, Issue 5, Pages (May 2017)

Prostate Cancer Epidemic in Sight?

Volume 63, Issue 2, Pages (February 2013)

Volume 59, Issue 2, Pages (February 2011)

Volume 74, Issue 1, Pages (July 2018)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 67, Issue 2, Pages (February 2015)

Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey John B. McKinlay, Carol L. Link European.

Volume 54, Issue 4, Pages (October 2008)

Elizabeth K. Bancroft, Rosalind A. Eeles

Prostate Cancer Detection: A View of the Future

Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance Adam B. Weiner, Ruth Etzioni, Scott E. Eggener

Volume 68, Issue 3, Pages (September 2015)

Volume 67, Issue 3, Pages (March 2015)

Volume 56, Issue 2, Pages (August 2009)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 73, Issue 4, Pages (April 2018)

Laurent Boccon-Gibod European Urology Supplements

Volume 64, Issue 6, Pages (December 2013)

Prostate Cancer Epidemic in Sight?

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

11C-Choline Positron Emission Tomography for the Evaluation after Treatment of Localized Prostate Cancer I.J de Jong, J Pruim, P.H Elsinga, W Vaalburg,

Volume 53, Issue 6, Pages (June 2008)

Volume 53, Issue 4, Pages (April 2008)

Volume 66, Issue 2, Pages (August 2014)

Volume 62, Issue 4, Pages (October 2012)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 71, Issue 1, Pages (January 2017)

Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study Stephen H. Culp, Paul.

Volume 68, Issue 4, Pages (October 2015)

Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels

Volume 50, Issue 5, Pages (November 2006)

Volume 55, Issue 6, Pages (June 2009)

Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 71, Issue 5, Pages (May 2017)

Volume 53, Issue 1, Pages (January 2008)

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

Volume 59, Issue 4, Pages (April 2011)

European Urology is “Your” Journal

Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg

Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders

Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature Liliana Vartolomei, Shahrokh F. Shariat, Mihai.

Volume 74, Issue 6, Pages (December 2018)

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.

Volume 68, Issue 2, Pages (August 2015)

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Volume 53, Issue 2, Pages (February 2008)

Volume 51, Issue 2, Pages (February 2007)

Volume 54, Issue 3, Pages (September 2008)

Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer Sam Ladjevardi, Gabriel Sandblom, Anders Berglund, Eberhard Varenhorst European Urology Volume 57, Issue 4, Pages 631-640 (April 2010) DOI: 10.1016/j.eururo.2009.03.007 Copyright © 2009 European Association of Urology Terms and Conditions

Fig. 1 Flow chart of cohort assembly. PSA=prostate-specific antigen; WHO=World Health Organisation; T4=tumour classification 4; N1=regional lymph node metastasis; M1=distant metastasis. European Urology 2010 57, 631-640DOI: (10.1016/j.eururo.2009.03.007) Copyright © 2009 European Association of Urology Terms and Conditions

Fig. 2 Relative survival: (a) Gleason score 2–6; (b) Gleason score 7; (c) Gleason score 8–10. European Urology 2010 57, 631-640DOI: (10.1016/j.eururo.2009.03.007) Copyright © 2009 European Association of Urology Terms and Conditions

Fig. 3 Ratio of observed deaths to expected deaths (patients diagnosed 2000–2006). European Urology 2010 57, 631-640DOI: (10.1016/j.eururo.2009.03.007) Copyright © 2009 European Association of Urology Terms and Conditions